A clinical follow-up of omalizumab in routine treatment of allergic asthma monitored by CD-sens.

S Gunnar O JohanssonGunnar LiljaJenny HallbergAnna Nopp

Published in: Immunity, inflammation and disease (2018)

By the use of the objective laboratory method CD-sens, which effectively measure the direct effect of omalizumab, that is, the IgE-mediated part of the allergic asthma, in combination with clinical parameters it might be possible to more effectively monitor and treat IgE-mediated allergic asthma.

Keyphrases

allergic rhinitis
chronic obstructive pulmonary disease
lung function
nk cells
clinical practice
cystic fibrosis
replacement therapy